Kave Moloudi | Oxidative stress | Research Excellence Award

Dr. Kave Moloudi | Oxidative stress | Research Excellence Award 

Caen-Normandy University, France

Dr. Kave Moloudi is an internationally recognized scientist specializing in nanotheranostics, radiobiology, photodynamic therapy, and cancer nanomedicine. His academic and research activities focus on integrating nanotechnology with biomedical sciences to develop innovative therapeutic and diagnostic solutions for cancer treatment. Through extensive interdisciplinary collaborations, Dr. Moloudi has contributed to significant advancements in nanoparticle-based drug delivery systems, molecular imaging, radiotherapy enhancement, and tumor-targeted therapies. His strong publication profile, high citation count, and impactful scientific reviews demonstrate his growing influence within the global biomedical research community. He has collaborated with prominent researchers and institutions across multiple countries, strengthening international scientific partnerships and knowledge exchange. Dr. Moloudi’s work reflects originality, technical expertise, and dedication to improving translational cancer therapies through innovative biomedical technologies. His contributions to oncology and nanomedicine research continue to gain academic recognition, establishing him as a respected and promising researcher committed to advancing modern healthcare science and therapeutic innovation worldwide.

Professional Profile

Education

Dr. Kave Moloudi has developed a strong academic foundation in biomedical sciences, nanotechnology, radiobiology, and cancer therapy through advanced education and specialized scientific training. His educational journey reflects a deep commitment to interdisciplinary learning, combining principles of medicine, molecular biology, physics, and nanoscience to address complex healthcare challenges. Through academic research and technical coursework, he gained expertise in photodynamic therapy, nanoparticle engineering, imaging technologies, and therapeutic innovation. His educational background prepared him to conduct high-quality translational research and contribute to emerging areas of nanomedicine and oncology. Throughout his studies, Dr. Moloudi demonstrated analytical thinking, scientific curiosity, and dedication to advancing biomedical knowledge. His academic preparation also enabled him to collaborate effectively with international researchers and contribute to peer-reviewed scientific literature. The combination of theoretical knowledge and practical research experience has positioned him as a capable scientist actively supporting innovation in cancer treatment and modern biomedical technologies.

Professional Experience

Dr. Kave Moloudi possesses extensive research experience in nanomedicine, radiobiology, molecular imaging, and photodynamic cancer therapy. His professional activities involve interdisciplinary scientific investigations focused on improving therapeutic efficiency and advancing innovative biomedical applications. Through affiliations with international research institutions and universities, he has contributed to collaborative projects addressing cancer treatment strategies, nanoparticle-mediated therapies, and translational medicine. Dr. Moloudi has actively participated in experimental research, publication development, and scientific communication within the biomedical and oncology communities. His experience includes working alongside researchers from medical sciences, nanotechnology, and molecular medicine backgrounds, strengthening his multidisciplinary expertise. He has also contributed to reviews and investigations exploring therapeutic enhancement, tumor targeting, and advanced drug delivery systems. Through continuous involvement in scientific innovation and collaborative research environments, Dr. Moloudi has built a respected academic profile characterized by technical competence, research productivity, and dedication to improving healthcare technologies and biomedical treatment methodologies.

Research Interest

Dr. Kave Moloudi’s research interests focus on nanotheranostics, photodynamic therapy, cancer nanomedicine, radiobiology, molecular imaging, and advanced therapeutic technologies. His scientific investigations aim to improve cancer diagnosis and treatment using nanoparticle-based drug delivery systems, radiosensitizers, and innovative biomedical materials. He is particularly interested in enhancing the effectiveness of radiotherapy and photodynamic therapy while minimizing side effects associated with conventional cancer treatments. Dr. Moloudi also explores the biological interactions of nanoparticles, tumor microenvironment modulation, fluorescence imaging, and targeted therapeutic strategies for oncology applications. His work integrates nanotechnology, molecular medicine, and biomedical engineering to develop translational healthcare solutions with clinical relevance. Additionally, his research addresses immune modulation, apoptosis induction, and combination therapies designed to optimize treatment outcomes in cancer patients. Through interdisciplinary collaboration and innovative scientific approaches, Dr. Moloudi continues contributing to the advancement of personalized medicine, biomedical innovation, and next-generation cancer therapeutics.

Award and Honor

Dr. Kave Moloudi has gained substantial academic recognition through his influential research publications, strong citation record, and growing international scientific reputation in biomedical and nanomedicine research. His scholarly impact is demonstrated by a high h-index and numerous widely cited articles in respected journals related to oncology, nanotechnology, and molecular medicine. These achievements reflect the scientific community’s acknowledgment of his innovative contributions to cancer therapy and biomedical applications. His collaborations with internationally recognized researchers and institutions further highlight his professional credibility and research excellence. Dr. Moloudi’s work on photodynamic therapy, nanoparticle-based treatments, and radiobiology has attracted considerable academic attention and established him as a valuable contributor to modern healthcare research. Although formal public award listings may be limited, his publication achievements, citation influence, and interdisciplinary scientific advancements serve as indicators of distinction and professional accomplishment within the global biomedical and cancer research communities.

Conclusion

Dr. Kave Moloudi is a highly promising and accomplished researcher whose scientific contributions have significantly advanced nanomedicine, cancer therapy, radiobiology, and biomedical innovation. His interdisciplinary expertise, strong publication record, and international collaborations demonstrate a sustained commitment to improving modern healthcare research and therapeutic technologies. Through innovative investigations involving nanoparticles, molecular imaging, and photodynamic therapy, he has contributed valuable knowledge to oncology and translational medicine. His research impact, supported by impressive citation metrics and respected scientific publications, reflects both academic excellence and growing global recognition. Dr. Moloudi continues to strengthen his influence within the international biomedical research community through collaborative scientific efforts and consistent scholarly productivity. His dedication to advancing cancer treatment methodologies and improving patient-centered therapeutic approaches highlights his potential for future leadership in biomedical sciences. Overall, Dr. Moloudi represents a respected researcher with exceptional capability, innovation, and commitment to scientific advancement and healthcare improvement.

Publications Top Notes

Title: Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy
Authors: A. Narmani, R. Jahedi, E. Bakhshian-Dehkordi, S. Ganji, M. Nemati, et al.
Year: 2023
Citation: 96 Citations

Title: Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy
Authors: M. Keshavarz, K. Moloudi, R. Paydar, Z. Abed, J. Beik, H. Ghaznavi, et al.
Year: 2018
Citation: 88 Citations

Title: Resveratrol as an enhancer of apoptosis in cancer: a mechanistic review
Authors: M. Ashrafizadeh, S. Taeb, H. Haghi-Aminjan, S. Afrashi, K. Moloudi, et al.
Year: 2021
Citation: 70 Citations

Title: Modulation of the immune system by melatonin; implications for cancer therapy
Authors: M. Moslehi, R. Moazamiyanfar, M.S. Dakkali, S. Rezaei, N. Rastegar-Pouyani, et al.
Year: 2022
Citation: 57 Citations

Title: Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study
Authors: R. Abdollahzadeh, M.S. Fard, F. Rahmani, K. Moloudi, A. Azarnezhad
Year: 2016
Citation: 51 Citations

Xinxia Li | Nuclear Physics | Best Researcher Award

Prof. Dr. Xinxia Li | Nuclear Physics | Best Researcher Award

Prof. Dr. Xinxia Li, University of South China, China

Prof. Dr. Xinxia Li, a distinguished physicist, specializes in magnetically controlled fusion plasmas. With a Ph.D. in Nuclear Science and Technology from the University of South China, he has extensive expertise in theoretical and computational plasma physics. Currently, a professor at the University of South China, Prof. Li’s research includes radio-frequency wave heating, magnetohydrodynamic instability in tokamak devices, and advancements in Heavy Ion Beam-driven Magnetized Inertial Fusion.

PROFILE

Scopus  Profile

Educational Detail

Prof. Dr. Xinxia Li earned his Ph.D. in Nuclear Science and Technology in 2012 from the University of South China, China. He previously obtained his Master’s degree in Theoretical Physics in 2006 from Xiangtan University, China.

Professional Experience

Prof. Li conducted postdoctoral research at the Institute of Plasma Physics, Chinese Academy of Sciences, from 2012 to 2014, focusing on advanced studies in plasma physics. Since 2017, he has been serving as a Professor of Physics at the University of South China, where he continues to contribute significantly to the academic and research community.

Research Interest

Prof. Li is dedicated to the theoretical analysis and numerical simulation of magnetically controlled fusion plasmas. His expertise includes radio-frequency wave heating and current drive in tokamak devices, as well as magnetohydrodynamic instability in tokamak plasmas. In recent years, his research has expanded to encompass the ionization process of targets in Heavy Ion Beam (HIB)-driven Magnetized Inertial Fusion (MIF).

 

Top Notable Publications

Article Title: GTC simulation of turbulence transport at internal transport barrier of HL-2M tokamak

Authors: Xiao, Z., Li, X., Wang, S.

Year: 2024

Citations: 0

Article Title: Study of the effect of lower hybrid wave heating on the coaxial-tangential neutral beam collisional torque in EAST tokamak

Authors: Yang, M., Zhang, X.-J., Li, X.-X., Lü, B., Gu, J.-R.

Year: 2024

Citations: 0

Article Title: Synergistic current drive of helicon wave and lower hybrid wave in HL-2M

Authors: Liu, G.-N., Li, X.-X., Liu, H.-B., Sun, A.-P.

Year: 2023

Citations: 1

Article Title: Impact ionization of highly charged ion-atom collisions considering strong magnetic field and plasma screening effect

Authors: Li, G., Gu, J., Jiao, Z., Zhang, S., Li, X.

Year: 2023

Citations: 0

Article Title: Observation and analysis of lower-hybrid-current-drive density limit in EAST

Authors: Li, M.H., Baek, S.G., Wallace, G.M., Zhang, X.J., Gong, X.Z.

Year: 2022

Citations: 5

Article Title: Collisions of proton or highly charged ion-atom in a strong magnetic field and dense quantum plasmas

Authors: Li, G., Zhang, S., Jiao, Z., Yan, Q., Li, X.

Year: 2022

Citations: 1

Article Title: Optimization of helicon wave current drive in HL-2M tokamak

Authors: Liu, H.B., Liu, G.N., Sun, A.P., Xiao, Z.Y., Li, X.X.

Year: 2022

Citations: 3

Article Title: Charge transfer in collisions of H+, Li3+, Be4+ and O7+ ions with He atom based on 4-classical trajectory Monte Carlo method

Authors: Li, G.-Z., Zhang, S., Jiao, Z.-H., Li, X.-X.

Year: 2022

Citations: 1

Article Title: Numerical simulation of helicon waves current drive in the HL-2M tokamak for the steady-state scenario

Authors: Liu, H.B., Li, X.X., Xiao, Z.Y., Zhang, D.Z., Sun, A.P.

Year: 2021

Citations: 3

Article Title: Optimization of helicon wave off-axis current drive in CFETR tokamak

Authors: Li, X., Li, G., Liu, H.

Year: 2021

Citations: 4

Conclusion

Prof. Dr. Xinxia Li’s career achievements make him a deserving candidate for the Best Researcher Award, recognizing his outstanding contributions to the field of nuclear and plasma physics.

 

 

 

 

 

 

 

 

 

 

 

 

Suneela Sardar | Nuclear | Best Researcher Award

Dr. Suneela Sardar | Nuclear | Best Researcher Award

Dr. Suneela Sardar, University of Lincoln, United Kingdom

Dr. suneela sardar is a Senior Lecturer in Chemical Engineering at the University of Lincoln, UK, with a diverse research portfolio spanning sustainable process engineering, minerals processing, and nanomaterials. She earned her PhD from the University of Leeds, where she focused on nanoparticle synthesis. With extensive experience in both academia and industry, Dr. sardar has contributed to nuclear reactor safety research, sustainable mineral processing, and engineering education, and she holds significant expertise in radioactive materials handling and the characterization of engineering materials. Her teaching and mentorship roles at the University of Lincoln underscore her commitment to advancing the field of chemical engineering and nurturing future engineers.

PROFILE

Orcid Profile

Scopus Profile

Educational Details

Dr. suneela sardar holds a PhD in Chemical Engineering from the University of Leeds, United Kingdom, where she specialized in the manufacturing of pyrochlore nanoparticles via the sol-gel method (2016–2020). Her academic credentials also include a Master’s in Chemical Engineering with a focus on Industrial Pollution Control from the University of Engineering and Technology, Lahore, Pakistan (2011–2012). Dr. sardar further enhanced her qualifications with an MBA in Human Resource Management from the Virtual University of Pakistan (2009–2011) and a BSc in Chemical Engineering, specializing in Biochemical Engineering, from the University of the Punjab, Lahore, Pakistan (2004–2008). Additionally, she holds a Fellowship in AdvancedHE (2024) and completed a professional development course for external examiners the same year.

Professional Experience

Dr. sardar is currently a Senior Lecturer in Chemical Engineering at the University of Lincoln, UK, where she also serves on the External Examiners Committee, manages multiple engineering modules, and supervises undergraduate and postgraduate research projects. She joined the University of Lincoln in 2023, initially as a Lecturer. Before this, Dr. sardar was a Senior Research Associate at Lancaster University, UK (2021–2023), where she contributed to pioneering research in 0Power-Molten Salt Reactor experiments. Her responsibilities involved managing radioactive material risk assessments, conducting phase identification studies, and coordinating with academic and industrial partners. She previously served as a Postdoctoral Research Fellow at the University of Leeds (2020–2021), focusing on sustainable minerals processing and chemical beneficiation. Her early career includes a lecturing position at the NFC Institute of Engineering & Fertilizer Research in Faisalabad, Pakistan (2009–2016), where she was involved in teaching, laboratory development, and supervising design projects.

Research Interests

Dr. sardar’s research interests encompass sustainable process engineering, minerals processing, nanomaterials, nuclear lab practices, and renewable energy technologies. She has specialized skills in characterizing materials, synthesizing nanomaterials, and using advanced techniques such as TGA/DSC, X-ray diffraction, UV-Vis spectrophotometry, and SEM. Dr. sardar is also well-versed in working with radioactive materials and has a solid background in surface modification of materials and crystallization processes.

Technical Skills

Dr. sardar’s technical expertise includes working with radioactive materials and handling nuclear lab practices, synthesis and characterization of nanomaterials, and advanced analysis techniques such as powder and surface characterization. She is proficient in using analytical tools like TGA/DSC, XRD, XRF, SEM, AAS, UV-Vis Spectroscopy, TEM, and Raman spectroscopy. Additionally, she has skills in software applications such as ANSYS FLUENT, MATLAB, Highscore Plus, and Z View for data visualization, modeling, and materials analysis

Top Notable Publications

sardar, s. (2024). “Multiscale Approach of Investigating the Density of Simulated Fuel for a Zero Power Reactor.” Journal of Nuclear Engineering, DOI: 10.3390/jne5030026.

sardar, s. (2024). “Effect of B-site Cationic Substitution on the Structural, Spectroscopic, and Conductivity Behaviour of Ho₂(Hf₁₋ₓZrₓ)₂O₇ (x=0 and 1).” Ceramics International, DOI: 10.1016/j.ceramint.2024.02.125.

sardar, s. (2024). “Short Life Fission Products Extracted from Molten Salt Reactor Fuel for Radiopharmaceutical Applications.” Applied Radiation and Isotopes, DOI: 10.1016/j.apradiso.2023.111146.

sardar, s. (2021). “Microstructure and Impedance Spectroscopy of High Density Holmium Hafnate (Ho₂Hf₂O₇) from Nanoparticulate Compacts.” Materials Science and Engineering B: Solid-State Materials for Advanced Technology, DOI: 10.1016/j.mseb.2020.114989.

sardar, s. (2021). “Rheological Behavior of Stabilized Diamond-Graphene Nanoplatelets Hybrid Nanosuspensions in Mineral Oil.” Journal of Molecular Liquids, DOI: 10.1016/j.molliq.2021.115509.

sardar, s. (2020). “Environmentally Sustainable Facile Synthesis of Nanocrystalline Holmium Hafnate (Ho₂Hf₂O₇): Promising New Oxide-Ion Conducting Solid Electrolyte.” SN Applied Sciences, DOI: 10.1007/s42452-020-2336-9.

sardar, s. (2020). “Influence of Processing Conditions on the Ionic Conductivity of Holmium Zirconate (Ho₂Zr₂O₇).” Ceramics International, DOI: 10.1016/j.ceramint.2020.01.177.

sardar, s. (2019). “Structural Study of Holmium Zirconate Nanoparticles Obtained Through Carbon Neutral Sol-Gel Process.” Thermochimica Acta, DOI: 10.1016/j.tca.2019.04.003.

Conclusion

Dr. suneela sardar’s experience in chemical and nuclear engineering research, combined with her technical expertise, teaching proficiency, and professional involvement, presents a compelling case for her candidacy for the Best Researcher Award. Her work, particularly in materials characterization and sustainable engineering, has made valuable contributions to her field, and her commitment to professional growth reinforces her standing as a leading researcher in her discipline.